EMA (EU)
EVENT
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - September 2026
Published: 9/10/2026Detected: 8/13/2026
Summary preview
Clarifies that EMA will continue running monthly Q&A clinics through the end of 2026 for questions on the XEVMPD service, with a specific session scheduled for September 2026.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountsafety
labeling
clinical
manufacturing
quality
#XEVMPD
#eXtended EudraVigilance Medicinal Product Dictionary
#regulatory data management
#PMS
#referentials management
Official Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system10/12/2026
- First European Medicines Agency (EMA) - International Society for Cell and Gene Therapy (ISCT) bilateral meeting10/12/2026
- Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - October 202610/8/2026
- PMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API) – October 202610/8/2026
- SPOR and XEVMPD status update webinar - Q4 202610/7/2026